Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Neoplasms

Explore clinical trials studying Fallopian Tube Neoplasms. Study availability and eligibility vary by location and protocol.

37 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Neoplasms trial results

Completed

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

NCT00103545

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
Locations
  • Clinic for Gynecology and Gyn. Oncology, Humboldt University Berlin, Germany
  • University Clinic Carl Gustav Carus, Gynecological hospital Dresden, Germany
  • Gynecologic Hospital Düsseldorf, Germany
  • University Gynecologic Hospital Essen, Germany
View Trial Details
Active, Not Recruiting

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

NCT05605535

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Omega Hospitals Visakhapatnam, Andhra Pradesh, India
  • King George Hospital Visakhapatnam, Andhra Pradesh, India
  • Himalaya Cancer Hospital and Research Institute Vadodara, Gujarat, India
  • Kailash Cancer Hospital and Research Centre Vadodara, Gujarat, India
View all 14 locations
View Trial Details
Active, Not Recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

NCT04498117

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Health Clinical Research Center Concord, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
View all 148 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

NCT05116189

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations
  • HonorHealth ( Site 0041) Phoenix, Arizona, United States
  • Marin Cancer Care ( Site 0055) Greenbrae, California, United States
  • Pacific Cancer Care ( Site 0028) Monterey, California, United States
  • Eisenhower Medical Center ( Site 0067) Rancho Mirage, California, United States
View all 187 locations
View Trial Details
Active, Not Recruiting

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

NCT05617755

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adnexal Diseases, +29 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • U of Colorado Cancer Center - Anschutz Medical Campus Aurora, Colorado, United States
  • U of Iowa Health Care Iowa City, Iowa, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

NCT05257408

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
Locations
  • Site 318 Phoenix, Arizona, United States
  • Site 277 Tucson, Arizona, United States
  • Site 350 Irvine, California, United States
  • Site 364 La Jolla, California, United States
View all 117 locations
View Trial Details
Active, Not Recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions
Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations
  • Huai'an First People's Hospital Huai'an, China
  • Nanjing Drum Tower Hospital Nanjing, China
  • Zhongda Hospital Southeast University Nanjing, China
  • The First Affiliated Hospital of Soochow University Suzhou, China
View Trial Details

Related conditions